Nicotianamine (NA), a metal chelator, is ubiquitous in higher plants. In humans, NA inhibits angiotensin Iconverting enzyme (ACE), and consequently reduces high blood pressure. Nicotianamine is synthesized from the trimerization of S-adenosylmethionine (SAM) by NA synthase (NAS). Here, we aimed to produce large amounts of NA fermentatively by introducing the Arabidopsis AtNAS2 gene into Saccharomyces cerevisiae strain SCY4. This strain can accumulate up to 100 times the usual amount of SAM, and this is considered desirable for overproduction of NA. Nicotianamine was produced in the engineered yeast, and the NA level increased with incubation time until the stationary phase. The maximum concentration of intracellular NA obtained was 766 AE 33 g/g wet weight. Successful production of NA in S. cerevisiae should pave the way for industrial production of this novel antihypertensive substrate.
Hypertension can lead to cerebral apoplexy and cardiovascular disease. The renin-angiotensin (R-A) system plays an important role in essential hypertension. Angiotensin I-converting enzyme (ACE) is a key enzyme in the R-A system. It catalyzes the hydrolysis of angiotensin I to generate a potent vasoconstrictor, angiotensin II. 1) Inhibition of ACE reduces blood pressure, and hence ACE inhibitors are widely used as antihypertensive agents. Moreover, the ACE inhibitory activities of various foods have been studied recently, with reports of ACE-inhibitory peptides in food proteins.
2) Some studies have investigated non-peptidyl ACE inhibitors, including nicotianamine (NA), a derivative of a non-proteogenic amino acid. 3, 4) Nicotianamine was found originally in tobacco 5) and has been found in all higher plants that have been examined. 6, 7) Nicotianamine chelates many metal cations and is thought to play an important role in the internal transport of metal nutrients, including iron (Fe). 8) In graminaceous plants, NA is also the essential intermediate of mugineic acid family phytosiderophores (MAs), natural Fe chelators secreted from the roots to solubilize Fe in the soil. [9] [10] [11] Nicotianamine is synthesized via the trimerization of S-adenosylmethionine (SAM) by NA synthase (NAS) (Fig. 1) . 12) In studies of the biosynthetic pathways of MAs, we have cloned many NAS genes from barley, Arabidopsis, rice, and maize. [13] [14] [15] [16] Given its antihypertensive effects, NA might be useful as an additive in functional foods or antihypertensive drugs, and the production of large amounts of NA would be very important commercially. We planned to produce large amounts of NA via fermentation by engineering Saccharomyces cerevisiae to produce NA. The yeast S. cerevisiae is one of the organisms widely used in industrial microbiology for the production not only of ethanol but of recombinant proteins, 17) bioactive substances, 18) and vaccines. 19) S. cerevisiae is also nonpathogenic, and, given its long history of application in the production of food and alcoholic beverages, it has been classified as a GRAS (generally regarded as safe) organism. 20) In addition, the well-established fermentation and process technology for large-scale production using S. cerevisiae make this organism attractive for use as a fermenter. Recently, S. cerevisiae has become the focus of more attention as a nutrient supplement to increase intake of essential amino acids, B vitamins, y To whom correspondence should be addressed. Fax: +86-3-5841-7514; E-mail: annaoko@mail.ecc.u-tokyo.ac.jp Abbreviations: ACE, angiotensin I-converting enzyme; Fe, iron; GRAS, generally regarded as safe; HPLC, high-performance liquid chromatography; MAs, mugineic acid family phytosiderophores; MTA, methylthioadenosine; NA, nicotianamine; NAS, nicotianamine synthase; R-A, renin-angiotensin; SAM, S-adenosylmethionine minerals, fibers, etc. Increasing the nutritional quality of such supplements by adding NA would make them more attractive for those troubled with hypertension. Although S. cerevisiae lacks a NAS gene, production of NA in the cell should follow the introduction of an NAS gene into S. cerevisiae using genetic engineering.
In this study, we introduced the Arabidopsis AtNAS2 gene, into S. cerevisiae strain SCY4. 21, 22) When SCY4 is grown in synthetic defined (SD) media supplemented with glycine and formate for its auxotrophy of serine, it accumulates about 100 times the usual amount of SAM. Since SAM is the precursor of NA, expression of NAS in SCY4 should lead to fermentative overproduction of NA. In addition, we investigated how fermentative production of NA can be optimized by evaluating the effects of three factors on the production of NA: growth phases, amount of SAM precursor, and copy numbers of the transgene. This is the first report on the fermentative production of NA as an antihypertensive substrate.
Materials and Methods
Plasmid construction. To express NAS, an integrative vector, pINNAS, and a high-copy episomal vector, pEPNAS, were engineered.
We constructed pINNAS ( Fig. 2A) as follows: The GAPDH promoter was amplified by polymerase chain reaction (PCR) using KOD-Plus-DNA polymerase (Toyobo, Osaka, Japan), primers 5 0 -AAGCTTTCGA-GTTTATCATTATCAATACTCGCCAT-3 0 and 5 0 -GG-TACCTTTGTTTATTTATGTGTGTTATTCGAAA-3 0 , and the S. cerevisiae genome as a template. The PCR product was cloned into pCR-BluntII-TOPO (Invitrogen, CA, USA) to construct the plasmid pCR-BluntII-TOPO::GAPDHpro. After confirming its DNA sequence using an ABI PRISM 310 (PE Applied Biosystems, Tokyo, Japan), this engineered plasmid was digested with Hind III and Kpn I, and the GAPDH promoter fragment was ligated into the Hind III and Kpn I site of pLacZi (Clontech, Palo Alto, CA), to produce pLacZi:: GAPDHpro.
With primers 5 0 -CACCATGGCTTGCCAAAACAA- An integrative vector, pINNAS (A), and an episomal vector, pEPNAS (B), were constructed. Both contain the AtNAS2 ORF under the control of the GAPDH promoter, to induce constitutive, strong expression of AtNAS2. In addition, the stop codon of AtNAS2 was deleted and the 3 0 terminus was fused to the sequence of the V5 epitope to enable detection of the AtNAS2-V5 epitope fusion protein using Western blot analysis with anti-V5-HRP-antibody.
TCTC-3
0 and 5 0 -CTCGATGGCACTAAACTCCTCGA-3 0 and the Arabidopsis genome as a template, PCR was used to amplify the AtNAS2 open reading frame sequence (AtNAS2 has no intron) with 5 0 -CACC-3 0 added at the 5 0 terminus and deletion of the stop codon. The PCR product was cloned into pENTR/D-TOPO (Invitrogen) to produce pENTR::AtNAS2. After confirmation of the sequence, it was transferred to pYES-DEST52 (Invitrogen) using LR Clonase (Invitrogen). At this point, the AtNAS2 sequence was conjugated inframe with the sequence of the V5 epitope tag and a 6xHis-tag. With this plasmid as a template and with primers 5
0 -GGTACCATGGCTTGCCAAAACAATCT-CGTTGTGAA-3 0 and 5 0 -GCTCCGGATCCAGCTTG-CAAATTAAAGCCTTCGAG-3 0 , PCR was performed to amplify the conjugated sequence of the AtNAS::V5 epitope::6xHis::CYC1 transcription terminal signal. The PCR product was cloned into pCR-BluntII-TOPO. After confirmation of the sequence, the engineered plasmid was digested with BamH I and Kpn I, and the conjugated sequence was ligated with pLacZi::GAPDHpro. This plasmid functions as an integrative vector to express NAS, and was designated pINNAS.
The vector pEPNAS ( Fig. 2B ) was constructed as follows: The vector pCR-BluntII-TOPO::GAPDHpro was digested with Pst I and Spe I, and the GAPDH promoter fragment was ligated into the Pst I and Spe I site of pYH23, 23) to produce pYHGAP. Using the primers 5 0 -GGTACCACAAGTTTGACAAAAAAGCT-GAAC-3 0 and 5 0 -GGTACCGCATGCAGCTTGCAAA-TTAAAGCCTTCGA-3 0 , and pYES-DEST52 (Invitrogen) as a template, PCR was performed to amplify the fragment between attR1 and the CYC1 transcription terminal signal in pYES-DEST52. The PCR product was cloned into pCR-BluntII-TOPO. After confirming the sequence, the engineered plasmid was digested with Kpn I and Sph I, and the fragment between attR1 and the CYC1 transcription terminal signal was ligated with pYHGAP digested with Kpn I and Sph I. This plasmid is an episomal vector that is used in S. cerevisiae to express genes of interest with the Gateway Technology (Invitrogen), and was designated pDESTGAPDH. The AtNAS2 open reading frame was transferred from pENTR::AtNAS2 to pDESTGAPDH using Clonase. The resulting plasmid functioned as an episomal vector to express NAS, and was designated pEPNAS.
Yeast strain. Saccharomyce. cerevisiae strain SCY4 (MATa ser1 leu2 his4 trp1 ura3-52 met13::CHIMERA-1) was used as the parent strain, 21, 22) and pINNAS, pLacZi, and pEPNAS were introduced into it. Yeast transformation was carried out using the Li-acetate transformation method. 24) Before transformation, the integrative vectors pINNAS and pLacZi were digested with StuI to linearize them for efficient integration.
Media. Yeast cells were grown in YPD (1% yeast extract, 2% peptone, and 2% glucose) or SD medium supplemented with the following where indicated: 20 mg L À1 glycine, and 250 mg L À1 formate. Agar (2%) was added to produce solid plate media. 25) PCR analysis. Yeast cells were inoculated in 3 ml of YPD medium and grown in a flask shaken at 120 rpm at 30 C overnight. The cells were harvested by centrifugation and washed with sterile water. DNA was extracted from the pellet, as described previously. 26) Using the extract as a template and primers 5 0 -CA-CCATGGCTTGCCAAAACAATCTC-3 0 and 5 0 -CTCG-ATGGCACTAAACTCCTCGA-3 0 , PCR was performed to amplify the AtNAS2 open reading frame sequence.
Western blot analysis. Yeast cells were inoculated in 3 ml YPD medium and grown in a flask shaken at 120 rpm at 30 C overnight. The culture was inoculated into 50 ml of fresh YPD, with the A 600 adjusted to 0.1. After a 12-h incubation under the same conditions, the cells were collected by centrifugation at 1,000 g and washed with sterile water. The pellet was crushed finely in liquid N 2 with a mortar and pestle. The procedure used for extraction of protein from the homogenates, separation of protein by SDS-PAGE, and Western blot analysis were described previously. 16) Western blot analysis was performed using anti-V5-HRP-antibody (Invitrogen). The blot was stained with diaminobenzidine.
Description of the growth curve. Yeast cells were inoculated in 50 ml of YPD medium and grown in a flask shaken at 120 rpm at 30 C overnight. After the cells were harvested by centrifugation and washed with sterile water, they were inoculated into 500 ml of fresh medium, with A 600 adjusted to 0.1. During subsequent incubation under the same conditions, A 600 was measured at the indicated times.
Intracellular NA analysis in yeast. Yeast cells were inoculated in 50 ml of YPD medium and grown in a flask shaken at 120 rpm at 30 C overnight. After the cells were harvested by centrifugation and washed with distilled water, they were inoculated into 500 ml of fresh medium, with the A 600 adjusted to 0.1. After they were incubated under the same conditions for the indicated times, the cells were harvested by centrifugation at 1,000 g and washed with sterile water. Amino acids were extracted from the cells into 60 volumes of water by disrupting the cells with glass beads. The extract was centrifuged at 8,000 g for 15 min. The supernatant was adjusted to pH 12 with NaOH and applied to columns of DOWEX 1 Â 4 (Muromachi Technos, Tokyo, Japan; CH 3 COO À form). The columns were washed with 100 ml of 0.2 M pyridine, and the fractions containing NA were eluted with 150 ml of 0.5 M CH 3 COOH and concentrated in a rotary evapo-rator at 40 C. High-performance liquid chromatography (HPLC) was used for quantitative analysis of the NAcontaining fractions. 10, 27) 
Results
Engineering S. cerevisiae to express NAS In a primary study, we tried to express the barley HvNAS gene in S. cerevisiae, but no expression of HvNAS1 protein was detected using Western blot analysis (data not shown). Since Weber et al. 28) successfully expressed the Arabidopsis AtNAS2 gene in Shizosaccharomyces pombe, we tried to express AtNAS2 in S. cerevisiae instead of HvNAS1. Integrative vector pINNAS was constructed ( Fig. 2A) and introduced into S. cerevisiae SCY4 (SCY4-pINNAS). pLacZi was also introduced into SCY4 as a vector control (SCY4-pLacZi). The introduction of the transgene was confirmed by PCR analysis using the AtNAS2 ORF (Fig. 3A) .
Protein was extracted from SCY4-pINNAS and SCY4-pLacZi. Western blot analysis with anti-V5-HRP antibody was used to detect the expression of the AtNAS2-V5 epitope fusion protein. A 40-kDa signal was detected only in the extracts from SCY4-pINNAS (Fig. 3B) . The calculated molecular weight of the AtNAS2-V5 epitope fusion protein was about 40.5 kDa, which agrees well with the signal detected.
Production of NA in engineered yeast
The intracellular production of NA in SCY4-pINNAS was determined by HPLC. SCY4-pINNAS and its vector control, SCY4-pLacZi, were first grown in YPD medium and then transferred to SD medium supplemented with serine, leucine, histidine, and tryptophan. They were harvested 12 h after transfer, and the intracellular NA was extracted and then quantified. The retention time of the authentic NA standard was about 72.9 min (Fig. 4D) , and a peak at similar retention time was detected only with extracts of SCY4-pINNAS (Fig. 4A, B) . Co-chromatographic analysis further identified this peak as NA (Fig. 4C) . This indicated that AtNAS2-V5 epitope fusion protein expressed in SCY4-pINNAS has the enzymatic activity and that NA was produced in the cells.
Nicotianamine concentration in the engineered yeast with growth proceeding
The growth curves of SCY4-pINNAS and SCY4-pLacZi (vector control) were determined by first growing them in YPD medium and then transferring them to SD medium supplemented with serine, leucine, histidine, and tryptophan (Fig. 5A) . No notable difference in growth was observed between SCY4-pINNAS and SCY4-pLacZi. This indicates that the intracellular NA in yeast did not affect its growth.
The intracellular concentration of NA in SCY4-pINNAS was determined by HPLC after growing and harvesting the cells at five time points. The NA level in the engineered yeast increased as the incubation proceeded (Fig. 5B) . Based on this result, we examined whether a larger amount of intracellular NA accumulated in SCY4-pINNAS with prolonged incubation. SCY4-pINNAS was incubated for 48 h, and the intracellular NA was quantified. The intracellular concentration of NA at 48 h was 328 AE 15 mg/g wet weight, only slightly higher than the intracellular concentration of NA at 24 h (307 AE 11 mg/g wet weight), indicating that the intracellular NA concentration increased only slightly after the cells reached the stationary phase.
Effects of the growth medium on the intracellular NA concentration of the engineered yeast
In order to optimize the production of NA in SCY4-pINNAS, we examined the effects of the growth medium on the intracellular NA concentration. YPD medium and SD medium supplemented with leucine, histidine, tryptophan, glycine and formate (SD+Gly/ For) were compared with SD medium supplemented with serine, leucine, histidine, and tryptophan (SD+ Ser). First, YPD is a rich medium, and yeast cells grow vigorously in it. In both SD+Ser and YPD, SCY4-pINNAS cells reached stationary phase at 12 h, although the A 600 of YPD was much higher than that of SD+Ser (YPD: 8:8 AE 0:5, SD+Ser: 1:7 AE 0:2), indicating that the growth rate of the cells in YPD was much higher than in SD+Ser. This vigorous cell growth in YPD might lead to overproduction of intracellular NA as a consequence of the activated metabolism. In addition, the parent strain SCY4 is auxotrophic for serine. When the cells are grown in SD medium supplemented with the organic compounds needed for auxotrophy, except with glycine and formate instead of serine, SCY4 accumulates more than 100 times more SAM. 21, 22) As SAM is a precursor of NA, a large amount of intracellular SAM should be converted into NA by growing SCY4-pINNAS in SD+Gly/For medium.
SCY4-pINNAS cells were first grown in YPD and then transferred to SD+Ser, fresh YPD, or SD+Gly/ For. They were harvested at stationary phase (SD+Ser: 24 h, YPD: 24 h, SD+Gly/For: 48 h after transfer), and the intracellular NA was extracted and then quantified (Fig. 6 ). There was slightly more intracellular NA in the cells grown in YPD than in SD+Ser, indicating that the production of NA in yeast is not related to its growth rate. By contract, the amount of intracellular NA in the cells grown in SD+Gly/For medium was about 180 mg/ Yeast cells were first grown in YPD and then transferred to SD supplemented with serine, leucine, histidine, and tryptophan (SD+Ser) at time point 0 h. The cells were harvested at times 3, 6, 9, 12, 15, and 24 h. The growth curves were determined by measuring the A 600 of three independent incubations (A). Three samples were prepared for NA measurement at times 6, 9, 12, 15, 24, and 48 h, and each sample was measured twice (B). g wet weight more than that in SD+Ser, indicating that a large amount of intracellular SAM increased the production of NA.
Effects of transgene copy number on the intracellular NA concentration of the engineered yeasts
To further optimize the production of NA in yeast, we examined the effects of the transgene copy number on the intracellular NA concentration. A high-copy episomal vector, pEPNAS (Fig. 2B) , was constructed and introduced into S. cerevisiae SCY4 (SCY4-pEPNAS). The introduction of the transgene was confirmed by PCR analysis using the AtNAS2 ORF, and expression of the AtNAS2-V5 epitope fusion protein was detected by Western blotting (data not shown). The intracellular concentration of NA was compared under conditions in which both SCY4-pINNAS and SCY4-pEPNAS hyperaccumulate SAM. Both SCY4-pINNAS and SCY4-pEPNAS cells were first grown in YPD and then transferred to SD supplemented with leucine, histidine, tryptophan, glycine, and formate, or to SD supplemented with histidine, tryptophan, uracil, glycine, and formate. Although the SD media differed slightly in terms of the supplements corresponding to the auxotrophic requirements of each strain and this difference affected the growth rate of each strain, both media contained glycine and formate, which led to hyperaccumulation of intracellular SAM in both strains. When the strains reached the stationary phase (SCY4-pINNAS: 48 h, SCY4-pEPNAS: 60 h after transfer), the cells were harvested, and the intracellular NA was extracted and then quantified (Fig. 7) . The amount of intracellular NA in SCY4-pEPNAS cells was about 280 mg/g wet weight more than that in SCY4-pINNAS cells. This indicates that high copy numbers of the transgene also contributed to increased production of NA.
Discussion
In this study, we succeeded in producing NA fermentatively by introducing the AtNAS2 gene into S. cerevisiae SCY4 (Fig. 4) . Intracellular NA did not affect the growth of the engineered yeast (Fig. 5A ), and the intracellular NA level increased as the incubation proceeded and the stationary phase was reached (Fig. 5B) . The intracellular NA concentration increased further when SAM, a precursor of NA, accumulated in the engineered yeast (Fig. 6) . The intracellular NA concentration also increased when the transgene was introduced with a high-copy episomal vector (Fig. 7) . The maximum concentration of intracellular NA was about 766 AE 33 mg/g wet weight (Fig. 7) .
The lack of any significant effect of NA on the growth of the yeast and the accumulation of NA with prolonged incubation (Fig. 5) indicate that NA was not toxic to S. cerevisiae and was stable in the cell. These points should be favorable for the fermentative production of NA using yeast as a fermenter.
The maximum concentration of intracellular NA was observed when the high-copy episomal vector pEPNAS was used (Fig. 7) . Although this type of vector is useful for laboratory-scale high-level expression of a transgene, the specific conditions used in industrial fermentation, in which cells are often cultured for long period in poorly defined media precluding selection pressure, make the vector less suitable for large-scale production. pMIRY2 is a vector that can be integrated in high copy numbers in the yeast genome, 29) and adopting vectors Both SCY4-pINNAS and SCY4-pEPNAS cells were first grown in YPD and then transferred to SD supplemented with leucine, histidine, tryptophan, glycine, and formate, or SD supplemented with histidine, tryptophan, uracil, glycine, and formate respectively. The cells were harvested at the stationary phase (SCY4-pINNAS: 48 h, SCY4-pEPNAS: 60 h after transfer). Three samples were prepared for NA measurement, and each sample was measured twice.
like pMIRY2 instead of high-copy episomal vectors should circumvent this problem in industrial fermentation.
Saccharomyces cerevisiae strain SCY4 is reported to be able to accumulate 100 times the usual amount of SAM (up to about 4 mmol/g wet weight). 21) If all the hyperaccumulated SAM in SCY4 could be converted to NA through trimerization of SAM by the introduced AtNAS2, the estimated amount of NA would be about ð4 Â 1=3 ¼Þ 1:3 mmol/g wet weight. The maximum amount of intracellular NA in the engineered yeast was about 2.5 mmol/g wet weight (766 AE 33 mg/g wet weight), and approximately two times higher than the estimated 1.3 mmol/g wet weight. This overproduction of NA beyond the estimate indicates that the large consumption of SAM must have activated further production of SAM, the newly synthesized SAM must have contributed to further production of NA, and the overproduction of NA must finally have been achieved.
AtNAS2-sGFP fusion protein is localized in the cytoplasm (Tsunoda et al., unpublished), and, although SAM is distributed between the cytosol and the vacuole, excess SAM is sequestered in the vacuole. 22) Since we speculated that the removal of the difference in the subcellular localization of AtNAS2 and compartmentalization of the excess SAM might enhance the production of NA, a vacuole mutant strain, SCY4vac, 22) was tested as the parental strain to express NAS in order to utilize the excess SAM in the vacuole as a precursor of NA. This mutant strain is defective in vacuolar morphogenesis and function. When it is grown in medium that induces the hyperaccumulation of SAM, its growth is arrested due to the presumed toxicity of excessive SAM in the cytosol. Moreover, this toxicity cannot be overcome by overexpressing any genes in a yeast multi-copy library. Therefore, we introduced pEPNAS into SCY4-vac, expecting that the excessive toxic cytosolic SAM would be converted into nontoxic NA. Contrary to our expectation, the expression of AtNAS2 did not rescue the growth arrest resulting from excessive cytosolic SAM (data not shown). Therefore, in order to overproduce NA in yeast, an approach that simply increases the amount of SAM in the metabolically active cytosolic pool is not effective because of the toxicity of SAM.
Since a large amount of intracellular SAM increased the production of NA (Fig. 6) , the trial of further hyperaccumulation of intracellular SAM should lead to further overproduction of NA. One possible approach is to activate the methionine salvage pathway. When three molecules of SAM are catalyzed to produce one molecule of NA (Fig. 2) , three molecules of methylthioadenosine (MTA) are produced as by-products. This MTA is recycled into SAM via the methionine salvage pathway. 30, 31) In graminaceous plants, NA is the essential intermediate of MAs, as mentioned in the introduction. When graminaceous plants synthesize a large amount of MAs, they induce strong expression not only of genes involved directly in the synthesis of MAs including NAS, 13, 14, 16) but of all genes in the methionine salvage pathway. 32, 33) The activated methionine salvage pathway functions as a source of SAM for the synthesis of large amounts of NA, which is ultimately converted into MAs. This biological evidence from plants should be applicable to enhance fermentative production of NA in yeast. By synchronizing strong expression of NAS and activating methionine salvage pathway as in graminaceous plants using metabolic engineering, the by-product MTA derived from the synthesis of NA should be recycled efficiently to SAM, and a high yield of NA is to be expected.
The maximum amount of intracellular NA in the engineered yeast was 766 AE 33 mg/g wet weight. This amount exceeds that in soybean (Glycine max L. cv Bert; 475 AE 3 mg/g dry weight), food very rich in NA. In this sense, this engineered yeast is very attractive as a new nutritional supplement. As a fermenter of NA, however, further improvement of its productivity should be implemented using metabolic engineering, as described above. This fermentative production of NA is an alternative to chemical synthesis for the commercial production of the antihypertensive substrate.
34) Currently, chemical synthesis of NA is very expensive ($40,000/g; T. Hasegawa, Tokyo, Japan). We believe that establishing an industrial system to produce NA by fermentation has the potential to make this compound more affordable and should contribute to its widespread use.
